NAD levels decline with age, and Dr. Verdin's lab has found that senescent cells secrete an enzyme that degrades NAD. He takes a deep dive into cell senescence and chronic inflammation.
Dr. Verdin is the president and chief executive officer of the Buck Institute for Research on Aging. A native of Belgium, Dr. Verdin received his Doctorate of Medicine (MD) from the University of Liege and completed additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research. Dr. Verdin is also a professor of medicine at the University of California, San Francisco.
